These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6334100)
21. A dysfunctional Mo1 glycoprotein is present on a subline of the KG1 acute myelogenous leukemia cell line. Dana N; Todd RF; Colten HR; Arnaout MA J Immunol; 1987 May; 138(10):3549-54. PubMed ID: 2437197 [TBL] [Abstract][Full Text] [Related]
22. New facts and speculations on human myeloid leukemias. Breitman TR; Gallo RC Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818 [TBL] [Abstract][Full Text] [Related]
23. Anti-KCA-3, a monoclonal antibody reactive with a rat complement C3 receptor, distinguishes Kupffer cells from other macrophages. Maruiwa M; Mizoguchi A; Russell GJ; Narula N; Stronska M; Mizoguchi E; Rabb H; Arnaout MA; Bhan AK J Immunol; 1993 May; 150(9):4019-30. PubMed ID: 8473747 [TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23. Maliszewski CR; Ball ED; Graziano RF; Fanger MW J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519 [TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha. Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050 [TBL] [Abstract][Full Text] [Related]
26. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor. Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863 [TBL] [Abstract][Full Text] [Related]
27. Modulation of thrombospondin receptor expression during HL-60 cell differentiation. Suchard SJ; Mansfield PJ; Dixit VM J Immunol; 1994 Jan; 152(2):877-88. PubMed ID: 7506739 [TBL] [Abstract][Full Text] [Related]
28. Induction of complement receptor expression in cell lines derived from human undifferentiated lymphomas. II. Characterization of the induced complement receptors and demonstration of the simultaneous induction of EBV receptor. Magrath I; Freeman C; Santaella M; Gadek J; Frank M; Spiegel R; Novikovs L J Immunol; 1981 Sep; 127(3):1039-43. PubMed ID: 6267130 [TBL] [Abstract][Full Text] [Related]
29. Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor. Lublin DM; Griffith RC; Atkinson JP J Biol Chem; 1986 May; 261(13):5736-44. PubMed ID: 2939068 [TBL] [Abstract][Full Text] [Related]
30. Biochemical characterization of membrane cofactor protein of the complement system. Ballard LL; Bora NS; Yu GH; Atkinson JP J Immunol; 1988 Dec; 141(11):3923-9. PubMed ID: 3053903 [TBL] [Abstract][Full Text] [Related]
31. Complement receptors on Raji cells. The presence of a new type of C3 receptor. Okuda T; Tachibana T Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548 [TBL] [Abstract][Full Text] [Related]
32. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line. Lucas DL; Webster HK; Wright DG J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386 [TBL] [Abstract][Full Text] [Related]
33. Biochemical and functional characterization of MCS-2 antigen (CD13) on myeloid leukemic cells and polymorphonuclear leukocytes. Sakai K; Hattori T; Sagawa K; Yokoyama M; Takatsuki K Cancer Res; 1987 Nov; 47(21):5572-6. PubMed ID: 3478135 [TBL] [Abstract][Full Text] [Related]
34. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856 [TBL] [Abstract][Full Text] [Related]
35. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils. Gerdes J; Klatt U; Stein H Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397 [TBL] [Abstract][Full Text] [Related]
36. Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Cole JL; Housley GA; Dykman TR; MacDermott RP; Atkinson JP Proc Natl Acad Sci U S A; 1985 Feb; 82(3):859-63. PubMed ID: 3871945 [TBL] [Abstract][Full Text] [Related]
38. Mouse C3b/C4b inactivator: purification and properties. Kai S; Fujita T; Gigli I; Nussenzweig V J Immunol; 1980 Dec; 125(6):2409-15. PubMed ID: 6776193 [TBL] [Abstract][Full Text] [Related]
39. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator. von Zabern I; Bloom EL; Chu V; Gigli I J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993 [TBL] [Abstract][Full Text] [Related]
40. Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. Dykman TR; Hatch JA; Atkinson JP J Exp Med; 1984 Mar; 159(3):691-703. PubMed ID: 6230413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]